Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy
Danan Li(Dana-Farber Cancer Institute), Takeshi Shimamura(Brigham and Women's Hospital), Hongbin Ji(Dana-Farber Cancer Institute), Liang Chen(Dana-Farber Cancer Institute), Henry J. Haringsma(Dana-Farber Cancer Institute), Kate McNamara(Dana-Farber Cancer Institute), Mei‐Chih Liang(Dana-Farber Cancer Institute), Samanthi A. Perera(Dana-Farber Cancer Institute), Sara Zaghlul(Dana-Farber Cancer Institute), Christa L. Borgman(Dana-Farber Cancer Institute), Shigeto Kubo(Beth Israel Deaconess Medical Center), Masaya Takahashi(Beth Israel Deaconess Medical Center), Yanping Sun(Brigham and Women's Hospital), Lucian R. Chirieac(Brigham and Women's Hospital), Robert F. Padera(Brigham and Women's Hospital), Neal I. Lindeman(Brigham and Women's Hospital), Pasi A. Jänne(Brigham and Women's Hospital), Roman K. Thomas(Max Planck Society), Matthew L. Meyerson(Broad Institute), Michael J. Eck(Dana-Farber Cancer Institute), Jeffrey A. Engelman(Harvard University), Geoffrey I. Shapiro(Brigham and Women's Hospital), Kwok‐Kin Wong(Brigham and Women's Hospital)
Cited by 235Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis